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Supplementary Methods 
We develop and benchmark an accurate and high-throughput predictor of MoRFs regions, called 
fMoRFpred, and apply it to characterize MoRFs on the genomic scale. This is motivated by the 
observation that the existing and widely-used predictor MoRFpred 1 is too slow to be used to 
perform large-scale predictions. In spite of this limitation MoRFpred enjoys a wide-spread use 
with over 1100 unique users from 58 countries since 2012 when the method was released. This 
method was referenced in dozens of studies, with a few recent examples including 
characterization of MoRFs in PTEN protein, membrane proteins, ribosomal proteins, kinases, 
viral proteomes, plant proteomes, and their contribution to prediction of protein function and 
formation of scaffolds 2-9. Our aim is to obtain predictive performance that is similar to that of 
MoRFpred while securing a substantial speedup. 
Datasets 
We use the same datasets as in Disfani et al. 1 to design and benchmark our predictive model. 
The design was performed using the TRAINING dataset with 421 chains with the annotated 
MoRFs. We test our model on four test datasets proposed in Disfani et al. 1: TEST (419 
proteins), TEST2012 (45 proteins which include new depositions when compared with the 
TRAINING and TEST datasets), EXPER2008-12 (8 proteins) and the NEGATIVE dataset (28 
proteins with no MoRFs). The EXPER2008-12 includes proteins with MoRFs in regions that 
were experimentally verified to be disordered in isolation. The four test datasets share <=30% 
sequence similarity with the TRAINING dataset. 
Evaluation protocols and measures 
The design and test protocol and evaluation criteria follow the work in Disfani et al. 1 The 
evaluation criteria include Predicted Positive Rate (PPR), Success Rate (SR) and Area Under the 
Receiver Operating Characteristic (AUC) curve. The PPR measure is defined as 
(TP+FP)/(TP+FN) where TP is the number of true positive samples (correctly predicted native 
MoRF residues), FN is the number of false negatives (MoRF residues predicted as non-MoRFs), 
FP is the number of false positives (non-MoRF residues predicted as MoRFs), and TN is the 
number of true negatives (correctly predicted native non-MoRF residues). The Receiver 
operating (ROC) curve is a plot of false positive rate (FPR) =  FP/(FP+TN) vs. true positive rate 
(TPR) = TP/(TP+FN) that is obtained by changing a cutoff to binarize predictions (MoRF vs. 
non-MoRF residue) from the numeric propensity generated by the predictive model. We also 
compute the SR measure that was design to estimate predictive quality in cases where the 
annotations are incomplete. A given protein is assumed to be predicted correctly if the average 
propensity of residues to form MoRFs predicted by the model for the native MoRFs is higher 
than for all residues in the protein. The SR value is the fraction of the correctly predicted proteins 
in a given dataset.  
 
The fMoRFpred was designed utilizing the 5 fold-cross validation on the TRAINING dataset. 
The final model was build using the entire TRAINING dataset and was tested on the four test 
datasets. We evaluated statistical significance of the differences in the predictive quality of 
fMoRFpred and other relevant predictors. For each test dataset, we randomly select 50% proteins 
10 times and calculate the 10 corresponding SR and AUC values. We compare the 10 paired 
results for each measurement between a given pair of predictors. Given that the measurements 
follow normal distribution, tested using Anderson-Darling test with the 0.05 significance level, 
we apply the paired t-test; otherwise we use the Wilcoxon-Mann-Whitney test. Differences are 
assumed statistically significant when p-value < 0.05. 
Design of fMoRFpred 
The design consists of several steps. First, every residues in a given protein sequence is encoded 
using a set of numerical features representing its physicochemical and biochemical properties 
and properties of its neighboring residues. Next, feature selection is used to select a subset of 
these features that are relevant to the prediction of MoRF residues. Then, we parameterize a 
linear Support Vector Machine (SVM) model that takes these selected features as an input to 
generate propensities for formation of MoRFs. Finally, we devise a filter to remove MoRFs that 
are predicted outside of intrinsically disordered regions (IDRs). 
Feature-based encoding of the input sequence 
We consider a comprehensive set of numerical features including amino acid composition, 
information derived from intrinsic disorder predicted by the IUPred 10 and Espritz 11 methods, 
secondary structure (SS) predicted with PSIPRED 12, and over 500 amino acid (AA) indices that 
quantify physicochemical properties of residues that were collected from the  AAindex database 
13. This information is processed using sliding windows centered on the predicted residues. We 
use the same window size of 25 residues as in Disfani et al. 1, which means that predictions for 
residues at position k in the sequence use information from residues at positions k-12, k-11, …, 
k, …, k+12. We use predictions of disorder and secondary structure for each position in the 
window and we also aggregate this and other information, such as AA indices and composition, 
in the window. More specifically, we calculate content of disorder and secondary structures and 
average values of AA indices over the whole window and smaller windows inside with sizes of 
3, 5, 7,…, 23 residues. We also compute difference between average values of the AA indices 
between predicted intrinsically disordered and ordered regions, coil and non-coil regions, helical 
and non-helical regions, and strand and non-strand regions in the whole window. Moreover, we 
calculate the difference between inner part of the window (residues in the center of the window) 
and their flanking residues, as explained in Disfani et al. 1. While the total number of features 
considered in the design of the MoRFpred was 1764, here we consider a much larger set of 7036 
features. The new features are related to the differences between regions of putative disorder and 
secondary structures and the features that consider smaller inner windows. Moreover, we also 
assure that the features can be computed rapidly, which means that we use only high-throughput 
predictors of disorder and secondary structure.  
Feature selection 
We use the two-step feature selection to select a subset of relevant (step 1) and non-redundant 
(step 2) features, which is inspired by the methodology used in 1. The selection is performed 
exclusively using the TRAINING dataset. The first step combines results of three methods to 
rank the considered 7036 features. Two methods rank features based on their correlation with the 
native MoRF annotations quantified using the point-biserial and Phi correlation coefficients for 
continuous and dichotomous features, respectively. This calculation is done in two different 
ways: using all the residues in the TRAINING dataset (referred as complete-data) and using a 
sampled subset of residues from the TRAINING dataset (referred as local-data). In the local-data 
case, we undersampled the non-MoRF residues in each protein to obtain 2:1 ratio with the MoRF 
residues. Since, as argued in 1, annotations of MoRF regions are incomplete and the residues 
surrounding the MoRF regions are less likely to be MoRFs, we selected the residues that flank 
MoRF regions. The values were computed as averages on the 5 training folds based on the 5-fold 
cross validation on the TRAINING dataset. The third method is a wrapper-based selection which 
ranks features based on their predictive performance measured by SR values when used 
individually with an SVM model with linear kernel and default parameters (complexity 
parameter C = 5) on 5-fold cross validation on the TRAINING dataset. Features with their 
absolute values of correlation coefficients and the SR values < 0.05 are removed and we 
maintain three lists of features for each of the three rankings.  
 
In the second step, we use the wrapper-based sequential forward feature selection on the features 
obtained from the first step for each of the three rankings. Starting with the top ranked feature, 
we accept the next ranked feature into our feature set only if this feature improves the SR values 
by at least 0.01 when compared with the prediction obtained using the feature set before the 
addition. We go through the sorted list of features once. The predictions are based on linear SVM 
model with default parameters (C = 5) using the 4+1 fold cross validation protocol, which was 
introduced in 1. This protocol includes 4-fold cross validation on 4 out of the 5 original folds and 
additional test in which these four folds are used together to build a model that is tested on the 
set-aside 5th fold. The use of the 4+1-fold cross validation helps to reduce over fitting into the 
TRAINING dataset. This sequential forward feature selection is performed on the sampled 
subset of residues from the TRAINING dataset (local-data). As a result, 13, 3, and 4 features 
were selected for the complete-data, local-data and the SR values based ranking.  
 
The predictive performance for the final selected set of features generated by the three feature 
selection methods and the combined set of 20 features based on the 5-fold cross validation on 
TRAINING dataset is shown in Supplementary Table S1. The complete-data method secures the 
best AUC and PPR, the local-data method achieves the best TPR, and the SR based ranking 
approach obtains the highest success rate. Combing the three sets of selected features together 
results in a design that outperforms the individual methods by improving success rate by at least 
0.068 and AUC by at least 0.01. Consequently, we use the combined set of 20 selected features.  
Parameterization of predictive model 
The 20 selected features are used together with a linear SVM classifier to implement our 
predictor. The selection of the SVM model is motivated by its use in the MoRFpred method and 
low runtime requirements. We attempted to parameterize the SVM model by performing a grid 
search over its complexity parameter C = 2n where n = -7,-6,… ,7 based on cross-validation on 
the TRAINING dataset. The predictive performance of this model did not improve when 
compared with the default value of C = 5 and thus we use the default value.  
Filtering of raw fMoRFpred predictions 
Since MoRF regions are embedded in usually longer disordered regions, we filter out our raw 
MoRF predictions that are not located in a putative disordered region as follows. If a predicted 
MoRF residue is classified as structured (ordered) by a given disorder predictor or a consensus of 
disorder predictors (i.e., ௗܲ ൐ ்ܲௗ where 	 ௗܲ is the propensity for disorder generated by the disorder predictor and ்ܲௗ is the threshold used to convert this propensity to binary prediction: disordered vs. structured residue), then we decrease the propensity ௠ܲ generated by fMoRFpred as follows: 
௠ܲ ൌ ൞ ௠ܲ െ ൭ ்ܲ௠ െ ൬
்ܲௗ െ ௗܲ
்ܲௗ
൰൱ 								ݓ݄݁݊	 ௗܲ ൏ ்ܲௗ
௠ܲ																																																					݋ݐ݄݁ݎݓ݅ݏ݁									
 
where ்ܲ௠ represents the threshold used to convert the propensity generated by fMoRFpred to binary prediction: MoRF vs. non-MoRF residue. If after applying the deduction the propensity 
௠ܲ is still above the threshold ்ܲ௠ then we lower it to a value just below the threshold. The formula reveals that we do not change the propensity ௠ܲ if prediction is inside a putative disordered region. Note that the ்ܲௗ values for Espritz were set either based on the FPR or Sw indices 11 and we considered both options.  
 
We empirically test using each of the five high-throughput disorder predictors individually 
(IUPred long regions, UIPred short regions, Espritz X-ray, Espritz NRM, and Espritz Disprot), 
and in consensus where the propensity  ௗܲ is computed as either the maximal, minimal or average value of the propensities generated by the five methods. The effects of the resulting 11 
approaches (each Espritz version uses two ்ܲௗ values) when filtering the predictions of fMoRFpred on the TRAINING dataset are summarized in Supplementary Table S1. We observe 
an improvement when compared with the results before the filtering (see “Combination of the 
three methods (20 features)” row). We selected the filter based on the consensus of the five 
methods with the propensity calculated as the maximal value since this approach provides the 
highest SR value, favorable reduction of PPR from 2.696 to 0.723 (overprediction of MoRF 
residues is reduced to a rate comparable with the rate of native MoRF annotations) and relatively 
high value of AUC. 
Benchmarking results 
We benchmark fMoRFpred on three test datasets that are independent from the TRAINING 
dataset (i.e., they share sequence similarity below 30%) and compare the results with a 
comprehensive set of three MoRF predictors, ANCHOR14 that predicts disordered protein 
binding regions, and 13 modern disorder predictors, see Supplementary Table S2. The 
predictions of disorder were used to predict MoRFs since the latter are usually located inside 
IDRs. The MoRF predictors include α-MoRF-PredI 15, α-MoRF-PredII 16, and MoRFpred 1. The 
Anchor method does not predicts MoRFs (short recognition motifs involved in protein binding) 
but longer protein binding regions that also undergo a disorder-to-order transition. The 
considered disorder predictors are the three version of Espritz (each using two thresholds to 
compute binary predictions of disorder based on SW and FPR measures) 11, the two versions of 
IUPred 10, MFDp 17, SPINED 18, MD 19, DISOCLUST 20 and DISOPRED2 21. We rank all 
methods according to the SR values on each test dataset and compute the average ranking. The 
fMoRFpred method achieves the second best SR value on each test datasets and overall. Only 
MoRFpred provides higher SR values, however this is at the expense of worse PPR values. Note 
that PPR = 1 when the number of predicted MoRF residues equals to the number of native MoRF 
residues and value higher (lower) than 1 indicates overprediction (underprediction). PPR values 
of fMoRFpred are close to 1 while MoRFpred overpredicts MoRFs by 180% on the TEST and 
TEST2012 datasets. This suggests that fMoRFpred can be used to correctly estimate the overall 
abundance of MoRF residues, although their location in the sequence is predicted better by 
MoRFpred based on its higher SR and AUC values. Although the success rates and AUC values 
of fMoRFpred are lower than of MoRFpred, they are still relatively high in the 62 to 67% range 
for SR and 0.59 to 0.67 for AUC, depending on the dataset used. Anchor provides lower 
predictive performance which is expected as it targets disordered protein binding regions which 
could be seen as a superset of MoRFs. This explains why its PPR values are higher and the 
overall performance is lower but still substantially better then random. The α-MoRF-PredІ and α-
MoRF-PredІІ methods were designed to predict MoRF that fold into helices upon binding and as 
such cannot predict other types of MoRFs. This explains their low success rates. The disorder 
predictors overpredict the MoRFs by large margin between 340% (Espritz Disprot on the 
EXPER2008-12 dataset) and 3560% (DISOCLUST on TEST2012). This is expected as MoRFs 
constitute only a small fraction of the IDRs that these methods predict. The success rates of 
Espritz designed using Disprot-based annotations of disorder are relatively good and are ranked 
3rd best behind fMoRFpred.  
 
We also test fMoRFpred and the other considered methods on the NEGATIVE dataset which 
includes only structured proteins that do not have MoRFs; see Supplementary Table S3. We 
measure FPR values which quantify how many residues were incorrectly predicted 
(overpredicted) as MoRFs. The fMoRFpred makes mistakes for only 0.9% of residues compared 
to 6.3% obtained by MoRFpred. Only a few other methods, such as α-MoRF-PredІ, α-MoRF-
PredІІ, Anchor, and Espritz Disprot have lower FPR values.  
 
We conclude that fMoRFpred can be used to accurately estimate abundance of MoRFs and 
provides reasonably good predictions of their location in the protein sequence, although these 
predictions are inferior to the predictions provided by MoRFpred. However, MoRFpred 
overpredicts MoRFs, which is evident based on its relatively high PPR values on the three test 
datasets and high FPR on the NEGATIVE dataset. The relatively good predictive quality of 
fMoRFpred could be attributed to the novel aspects of its design, in particular use of a 
comprehensive feature set and the disorder-based filter. 
Runtime analysis 
The high computational cost of MoRFpred was the main motivation behind the design of 
fMoRFpred. We compare the runtime of fMoRFpred, MoRFpred and Anchor based on 
predictions on the largest TEST dataset. We perform predictions with these methods on the same 
hardware using a Linux system with kernel version 3.5.0-28-generic x86_64. We divide proteins 
according to their length into ten equally-sized subsets and calculate average runtime over 
proteins in these subsets. Results are shown in Supplementary Figure S1. We observe that 
runtime is linearly proportional to the size of protein chain for the three methods, i.e., the runtime 
values are fit well by a linear function. Anchor is the fastest method and is two orders of 
magnitude faster than fMoRFpred, while fMoRFpred is over two orders of magnitude faster than 
MoRFpred. The new methods generates predictions in a second for an average sized protein with 
about 300 residues and in up to 10 seconds for a long protein with about 2000 residues. To 
compare MoRFpred takes about 1 hour to predict such long chains. Extrapolating from the 
runtime of fMoRFpred, prediction of MoRFs for the entire human genome that includes 
approximately 70,000 proteins would take 70,000 seconds, which translates into about 20 hours. 
We conclude that fMoRFpred implements a reasonable trade-off between relatively low runtime, 
which allows for genome-scale predictions on a single desktop computer, and good predictive 
performance, being more accurate than Anchor and substantially faster than MoRFpred. A 
webserver-based implementation of fMoRFpred is freely available at 
http://biomine.ece.ualberta.ca/fMoRFpred/. 
  
Supplementary Tables 
Supplementary Table S1. Comparison of prediction results using different feature selection and filter 
methods on the TRAINING dataset. Highest success rate (SR) values and AUCs for each design step are 
shown in bold font. 
 
Design step tested Method used PPR SR AUC 
Feature selection 
Complete-data ranking (13 features) 0.937 0.589 0.634 
Local-data ranking (3 features) 3.286 0.584 0.543 
Success rate ranking (4 features) 0.020 0.596 0.596 
Combination of the three methods (20 features) 2.696 0.664 0.644 
Filters of the raw 
predictions 
Consensus of 5 methods where Pd is set to maximal 
propensity generated by the five methods 0.723 0.676 0.640 
Espritz NMR (PTd value based on FPR) 1.170 0.671 0.642 
Espritz Disprot (PTd value based on SW) 1.408 0.671 0.645 
IUPred short regions 0.831 0.669 0.628 
Espritz NM (PTd value based on SW) 1.841 0.669 0.649 
Espritz X-ray (PTd value based on SW) 2.344 0.668 0.646 
Espritz X-ray (PTd value based on FPR) 2.033 0.666 0.650 
Consensus of 5 methods where Pd is set to average 
propensity generated by the 5 methods 0.723 0.658 0.624 
IUPred long regions 0.747 0.652 0.620 
Espritz Disprot (PTd value based on FPR) 0.472 0.652 0.627 
Consensus of 5 methods where Pd is set to minimal 
propensity generated by the five methods 0.723 0.632 0.604 
 
 
  
Supplementary Table S2. Predictive performance on the TEST, TEST2012 and EXPER2008-12 datasets. Results are ranked by success rate (SR) 
values. We consider 5 MoRF and 13 disorder predictors. All methods are ranked according to the SR value on each dataset and the average 
ranking is shown in the last column. Significance of the differences in the success rate (SR) and AUC values between fMoRFpred and each other 
method is shown in the “p” and “test” columns; +/=/– means that the predictive performance is significantly higher/ is not significantly different/ is 
significantly lower (t-test (t); Wilcoxon test (w); degrees of freedom = 9; p-value <0.05; details in the Methods section) when compared with a 
method in a given row. 
  Predictor 
 TEST dataset   TEST2012 dataset   EXPER2008-12 dataset  
Avg
RankPPR SR AUC Rank PPR SR AUC Rank PPR SR AUC 
 
Rank value p test value p test value p test value p test value p test value p test 
MoRF predictors 
MoRFpred 2.857 0.718 – t 0.672 – t 1 2.843 0.756 – t 0.697 = t 1 1.114 0.750 – w 0.636 – w 1 1 
fMoRFpred 0.956 0.663   0.648   2 0.995 0.667   0.671   2 0.643 0.625   0.590   2 2 
Anchor 12.820 0.611 + t 0.599 + t 5 14.339 0.578 + t 0.634 + t 5 6.229 0.500 + w 0.556 + w 5 5 
α-MoRF-PredІІ 5.096 0.303 + t N/A  w 16 5.923 0.311 + t N/A   16 2.143 0.250 + w N/A  w 9 16 
α-MoRF-PredІ 1.947 0.158 + w N/A  w 18 1.851 0.133 + t N/A   18 0.814 0.000 + w N/A  w 18 18 
Disorder predictors 
Espritz Disprot (SW) 18.402 0.616 + t 0.704 – t 3 22.193 0.533 + t 0.734 – t 9 9.033 0.625 + w 0.652 – w 2 3 
Espritz Dispot (FPR) 5.216 0.616 + t 0.704 – t 3 6.655 0.533 + t 0.734 – t 9 3.424 0.625 + w 0.652 – w 2 3 
MFDp 31.324 0.592 + t 0.535 + t 6 33.511 0.556 + t 0.620 + t 7 10.819 0.500 + w 0.337 + w 5 6 
IUPred short regions 16.015 0.537 + t 0.521 + t 7 17.375 0.600 + t 0.612 + t 3 7.024 0.250 + w 0.446 + w 9 7 
SPINED 25.575 0.513 + t 0.532 + t 8 31.479 0.467 + t 0.605 + t 11 9.948 0.250 + w 0.330 + w 9 11 
IUPred long regions 19.573 0.499 + t 0.521 + t 9 23.075 0.600 + t 0.618 + t 3 9.148 0.375 + w 0.471 + w 8 8 
MD 19.481 0.480 + t 0.598 + t 10 26.324 0.578 + t 0.679 = t 5 8.981 0.500 + w 0.616 – w 5 8 
DISOCLUST 30.202 0.449 + t 0.499 + t 11 35.636 0.556 + t 0.512 + t 7 9.914 0.250 + w 0.290 + w 9 10 
Espritz NMR (SW) 29.163 0.379 + t 0.493 + t 12 33.521 0.400 + t 0.549 + t 14 10.624 0.250 + w 0.350 + w 9 12 
Espritz NMR (FPR) 22.089 0.379 + t 0.493 + t 12 24.296 0.400 + t 0.549 + t 14 8.829 0.250 + w 0.350 + w 9 12 
Espritz X-ray (SW) 17.713 0.344 + w 0.597 + t 14 20.920 0.444 + t 0.687 = t 12 7.586 0.250 + w 0.481 + w 9 12 
Espritz X-ray (FPR) 12.632 0.344 + w 0.597 + t 14 14.800 0.444 + t 0.687 = t 12 5.548 0.250 + w 0.481 + w 9 12 
DISOPRED2 22.491 0.296 + t 0.506 + t 17 27.331 0.244 + t 0.547 + t 17 8.986 0.125 + w 0.310 + w 17 17 
 
Supplementary Table S3. Predictive performance on the NEGATIVE dataset. 
 
 Predictor ACC FPR 
MoRF predictors 
α-MoRF-PredІ 1.000 0.000 
α-MoRF-PredІІ 1.000 0.000 
Anchor 0.995 0.005 
fMoRFpred 0.991 0.009 
MoRFpred 0.937 0.063 
Disorder predictors 
Espritz_DP_FPR 1.000 0.000 
MFDp 0.984 0.016 
IUPredL 0.974 0.026 
MD 0.969 0.031 
DISOPRED2 0.967 0.033 
Espritz_Cx_FPR 0.956 0.044 
IUPredS 0.949 0.051 
SPINED  0.926 0.074 
DISOCLUST 0.925 0.075 
Espritz_NMR_FPR 0.913 0.087 
Espritz_DP_SW 0.910 0.090 
Espritz_Cx_SW 0.903 0.097 
Espritz_NMR_SW 0.792 0.208 
 
  
Supplementary Figures 
 
 
Supplementary Figure S1. Comparison of runtime on the TEST dataset for fMoRFpred, MoRFpred, and 
ANCHOR. Proteins were sorted by their sequence length and divided into 10 sets of equal size by their 
size. The plot reports average runtime and average sequence size for each of the 10 sets. All predictors 
were run on the same hardware. 
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